Victory Capital Management
TWST icon

Victory Capital Management’s Twist Bioscience TWST Stock Holding History

Victory Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.87M Buy
47,369
+1,958
+4% +$127K ﹤0.01% 1375
2026
Q1 		$2.16M Buy
45,411
+7,856
+21% +$352K ﹤0.01% 1583
2025
Q4 		$1.19M Sell
37,555
-9,690
-21% -$302K ﹤0.01% 1747
2025
Q3 		$1.33M Sell
47,245
-313,491
-87% -$9.5M ﹤0.01% 1725
2025
Q2 		$13.3M Sell
360,736
-4,693
-1% -$162K 0.01% 1024
2025
Q1 		$14.3M Sell
365,429
-6,862
-2% -$309K 0.01% 924
2024
Q4 		$17.3M Buy
372,291
+40,482
+12% +$1.83M 0.02% 904
2024
Q3 		$15M Buy
331,809
+23,638
+8% +$1.12M 0.01% 956
2024
Q2 		$15.2M Buy
308,171
+300,891
+4,133% +$12.3M 0.02% 914
2024
Q1 		$250K Sell
7,280
-161
-2% -$5.81K ﹤0.01% 2163
2023
Q4 		$274K Buy
+7,441
New +$172K ﹤0.01% 2150
2022
Q4 		– Sell
-301,362
Closed -$10.6M – 2708
2022
Q3 		$10.6M Buy
301,362
+295,353
+4,915% +$12.5M 0.01% 1048
2022
Q2 		$210K Buy
+6,009
New +$213K ﹤0.01% 2339
2022
Q1 		– Sell
-618,313
Closed -$47.9M – 2810
2021
Q4 		$47.9M Buy
618,313
+66,951
+12% +$6.87M 0.04% 581
2021
Q3 		$59M Buy
551,362
+53,644
+11% +$6.14M 0.06% 472
2021
Q2 		$66.3M Sell
497,718
-29,101
-6% -$3.38M 0.06% 440
2021
Q1 		$65.3M Sell
526,819
-31,526
-6% -$4.79M 0.07% 426
2020
Q4 		$78.9M Buy
558,345
+255
+0% +$28.3K 0.09% 347
2020
Q3 		$42.4M Sell
558,090
-40,376
-7% -$2.51M 0.05% 514
2020
Q2 		$27.1M Sell
598,466
-163,746
-21% -$5.88M 0.04% 659
2020
Q1 		$23.3M Buy
762,212
+478,722
+169% +$12.9M 0.04% 595
2019
Q4 		$5.95M Sell
283,490
-7,597
-3% -$178K 0.01% 1142
2019
Q3 		$6.95M Buy
291,087
+218,616
+302% +$6.36M 0.01% 1084
2019
Q2 		$2.1M Hold
72,471
– – ﹤0.01% 1130
2019
Q1 		$1.68M Sell
72,471
-1,630
-2% -$36.8K ﹤0.01% 1133
2018
Q4 		$1.71M Buy
+74,101
New +$1.64M ﹤0.01% 1074

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Victory Capital Management's TWST Position: Q2 2026 in Review

Victory Capital Management increased its Twist Bioscience (TWST) stake by 4.3% in Q2 2026, buying an estimated $127K and bringing the position to 47,369 shares worth $4.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1375.

Victory Capital Management first reported a position in TWST in Q4 2018 and has held it in 26 quarters since. The position peaked at $78.9M in Q4 2020. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Victory Capital Management held 47,369 shares of Twist Bioscience worth $4.87M as of Q2 2026.
  • Victory Capital Management bought 1,958 Twist Bioscience shares in Q2 2026, an estimated $127K.
  • Twist Bioscience made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1375 holding.
  • Victory Capital Management first reported a position in Twist Bioscience in Q4 2018 and has held it in 26 quarters since.
  • Victory Capital Management's Twist Bioscience position peaked at $78.9M in Q4 2020.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.